ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,667.86
1.23%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Oric Pharmaceuticals Inc (ORIC)

  7. Oric Pharmaceuticals Inc (ORIC) Noticias

ORIC Oric Pharmaceuticals Inc

9.71
0.19 (2.00%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Oric Pharmaceuticals Inc ORIC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.19 2.00% 9.71 17:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
9.77 9.48 10.05 9.71 9.52
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202415:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
15/4/202415:15GLOBEORIC Pharmaceuticals Announces First Patients Dosed Across..
08/4/202407:00GLOBEORIC Pharmaceuticals Presents Preclinical Data on Two..
05/4/202415:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
04/4/202415:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
11/3/202416:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/3/202415:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202415:10EDGAR2Form 8-K - Current report
11/3/202415:05GLOBEORIC Pharmaceuticals Reports Fourth Quarter and Full Year..
06/3/202415:30GLOBEORIC Pharmaceuticals to Present at the Leerink..
05/3/202415:30GLOBEORIC Pharmaceuticals Announces Multiple Presentations at the..
01/3/202415:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
14/2/202415:30GLOBEORIC Pharmaceuticals to Participate in the Citi 2024 Virtual..
04/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
02/2/202415:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
31/1/202415:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
26/1/202415:58EDGAR2Form S-3 - Registration statement under Securities Act of..
25/1/202412:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/1/202408:01EDGAR2Form 8-K - Current report
22/1/202407:30GLOBEORIC Pharmaceuticals Announces $125 Million Private..
09/1/202408:00EDGAR2Form 8-K - Current report
08/1/202407:30GLOBEORIC Pharmaceuticals Provides Initial Phase 1b Data for..
02/1/202415:30GLOBEORIC Pharmaceuticals to Present at the 42nd Annual J.P...
15/12/202315:32EDGAR2Form S-3 - Registration statement under Securities Act of..
11/12/202315:05EDGAR2Form 8-K - Current report
11/12/202311:00GLOBEInitial Phase 1 Dose Escalation Data for ORIC-533 in..
01/12/202315:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
09/11/202315:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
06/11/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202315:10EDGAR2Form 8-K - Current report
06/11/202315:10GLOBEORIC Pharmaceuticals Reports Third Quarter 2023 Financial..
03/11/202315:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
02/11/202308:00GLOBEORIC Pharmaceuticals to Present Initial Phase 1b Clinical..
23/10/202315:07EDGAR2Form 8-K - Current report
21/10/202306:30GLOBEInitial Phase 1 Dose Escalation Data of ORIC-114 in Patients..
17/10/202315:30GLOBEORIC Pharmaceuticals to Present Initial Phase 1b Clinical..
06/10/202315:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
20/9/202315:30GLOBEORIC Pharmaceuticals to Participate in the 2023 Cantor..
01/9/202315:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
30/8/202315:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
10/8/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:11EDGAR2Form 8-K - Current report
10/8/202315:05GLOBEORIC Pharmaceuticals Reports Second Quarter 2023 Financial..
04/8/202315:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
07/7/202315:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/6/202307:30GLOBEORIC Pharmaceuticals Announces $85 Million Private Placement..
02/6/202315:15GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
31/5/202315:10GLOBEORIC Pharmaceuticals to Participate in the Jefferies..
08/5/202315:05GLOBEORIC Pharmaceuticals Reports First Quarter 2023 Financial..
05/5/202315:15GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..

Su Consulta Reciente

NASDAQ
ORIC
Oric Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados